Brief: YiChang HEC ChangJiang Pharmaceutical Sees Net Profit Attributable Of RMB68 Million For Year
17/03/2023 13:29
March 17 (Reuters) - YiChang HEC ChangJiang
Pharmaceutical Co Ltd 1558.HK :
* SEES NET PROFIT ATTRIBUTABLE OF RMB68 MILLION FOR YEAR
* EXPECTED RESULT DUE TO EMERGING SIGNS OF RECOVERY IN
VOLUME OF
PRESCRIPTIONS IN FRONTLINE MEDICAL FACILITIES
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million